<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ariel Rechtman- PhD Student</title>
    <link
      rel="stylesheet"
      href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css"
    />
    <!-- Google Fonts -->
    <link
      href="https://fonts.googleapis.com/css2?family=Poppins:wght@600;700&display=swap"
      rel="stylesheet"
    />
    <link rel="stylesheet" href="styles.css">
</head>
<body>
 
    <header>
    <nav>
        <a href="index.html" id="logo">
            <img src="ArielRechtman.jpg" alt="Your Logo">
        </a>
        
      <i class="fas fa-bars" id="ham-menu"></i>
      <ul id="nav-bar">
        <li>
          <a href="index.html">Home</a>
        </li>
        <li>
          <a href="Articles.html">Publications</a>
        </li>
        <li>
          <a href="Education.html">Education</a>
        </li>
        <li>
          <a href="Prizes.html">Awards</a>
        </li>
        <li>
          <a href="Conferences.html">Conferences</a>
        </li>
        <li>
            <a href="Posters.html">Posters</a>
          </li>
      </ul>
    </nav>
</header> 
    <!-- Articles Section -->
    <section id="articles">
        <h1 class="page-headline" id="Article-headline">Posters</h1>
        <div class="section-break"></div> <!-- Divider element -->
        <br> 

        <ul class="ArticleList">
            <li> <span class="NameBold">Rechtman A</span>, Zveik O, Haham N, Freidman-Korn T, Vaknin-Dembinsky A. (2024)
                <br class="AritcleListBrake">
                <span class="ArtTitle"> Thyroid hormone dysfunction in MOGAD and other demyelinating diseases. </span>  
            <span class="JouName"> Accepted to be presented at the ECTRIMS 2024 Congress. </span> 
           </li>
 
 <li> <span class="NameBold">Rechtman A</span>, Zveik O, Vaknin-Dembinsky A (2024)
                <br class="AritcleListBrake">
                <span class="ArtTitle"> RNFL thickening predicts a relapsing MOGAD disease course. </span>  
            <span class="JouName"> Accepted to be presented at the ECTRIMS 2024 Congress. </span> 
           </li>

 <li> <span class="NameBold">Rechtman A</span>, Freidman-Korn T, Zveik O, Shweiki L, Hoichman G, Vaknin-Dembinsky A (2024)
                <br class="AritcleListBrake">
                <span class="ArtTitle"> Assessing the Applicability of the 2023 International MOGAD Panel Criteria in Real-world Clinical Settings. </span>  
            <span class="JouName"> Accepted to be presented at the ECTRIMS 2024 Congress. </span> 
           </li>

            <li> <span class="NameBold">Rechtman A</span>, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A (2023)
                <br class="AritcleListBrake">
                <span class="ArtTitle">Predicting the severity of MOGAD disease using immunological and imaging parameters.</span>  
            <span class="JouName">Presented at the GYSS24, Global Young Scientist Summit. </span> 
           </li>
           <li> <span class="NameBold">Rechtman A</span>, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A (2023) 
            <br class="AritcleListBrake">
            <span class="ArtTitle">A Protective Effect of Lower MHC-II Expression in MOGAD.</span>  
        <span class="JouName">Presented at the joint ECTRIMS-ACTRIMS MSMILAN2023 Congress.</span> 
       </li>
       <li> <span class="NameBold">Rechtman A</span>, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A (2023) 
        <br class="AritcleListBrake">
        <span class="ArtTitle">Volumetric Differences in MOGAD and NMOSD.</span>  
    <span class="JouName">Presented at the joint ECTRIMS-ACTRIMS MSMILAN 2023 Congress.</span> 
   </li>
   <li> <span class="NameBold">Rechtman A</span>, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A (2023) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">White Blood Cell Count Profile in MOGAD and Related Demyelinating Disorders.</span>  
<span class="JouName">Presented at the joint ECTRIMS-ACTRIMS MSMILAN2023 Congress.</span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Zveik O, Haham N, Brill L, and Vaknin-Dembinsky A. (2023)
    <br class="AritcleListBrake">
    <span class="ArtTitle">A protective effect of lower MHC-II expression in MOGAD. </span>  
<span class="JouName">Presented at the International Congress of Neuroimmunology 2023 ISNI Congress.</span> 
</li>
</li>
<li> <span class="NameBold">Rechtman A</span>, Haramati A, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A. (2023) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">IL-6 as a Blood Biomarker in NMOSD patients.</span>  
<span class="JouName">Presented at the International Congress of Neuroimmunology 2023 ISNI Congress.</span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Zveik O, Uliel B, Haham N, Vaknin-dembinsky A. (2022)  
    <br class="AritcleListBrake">
    <span class="ArtTitle">Volumetric brain loss at diagnosis correlates with a relapsing MOGAD disease course.</span>  
<span class="JouName">Presented at the annual meeting of the Israeli Neuroimmunology Association.</span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Haramati A, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A. (2022)
    <br class="AritcleListBrake">
    <span class="ArtTitle">IL-6 as a Blood Biomarker in NMOSD patients. A positive correlation between clinical status and imaging to IL-6 serum levels. </span>  
<span class="JouName">Presented at the ECTRIMS 2022 Congress.</span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. (2022) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">Short and long-term serology response of MS patients treated with natalizumab following two doses of mRNA COVID-19 vaccine (Pfizer).</span>  
<span class="JouName">Presented at the ECTRIMS 2022 Congress.</span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. (2022)
    <br class="AritcleListBrake">
    <span class="ArtTitle">Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine. </span>  
<span class="JouName">Presented at the ECTRIMS 2022 Congress.</span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. (2021)
    <br class="AritcleListBrake">
    <span class="ArtTitle"> Effect of cladribine on COVID-19 serology responses following 2 doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis.</span>  
<span class="JouName">Presented at the annual meeting of the Israeli Neurological Association. </span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. (2021) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">MS patients treated with natalizumab have a positive serology response to SARS-CoV-2 S1/S2 following vaccination with two doses of mRNA COVID-19 vaccine (Pfizer). </span>  
<span class="JouName">Presented at the annual meeting of the Israeli Neurological Association. </span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. (2021) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">Effect of cladribine on COVID-19 serology responses following 2 doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis. </span>  
<span class="JouName">Presented at ECTRIMS 2021 Virtual Congress. </span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Zveik O, Uliel B, Haham N, Vaknin-Dembinsky A. (2021) 
    <br class="AritcleListBrake">
    <span class="ArtTitle"> Volumetric brain loss at diagnosis correlates with a relapsing MOGAD disease course.</span>  
<span class="JouName">Presented at ECTRIMS 2021 Virtual Congress. </span> 
</li>
<li> <span class="NameBold">Rechtman A</span>, Brill L, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. (2021) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">MS patients treated with natalizumab have a positive serology response to SARS-CoV-2 S1/S2 following vaccination with two doses of mRNA COVID-19 vaccine (Pfizer).</span>  
<span class="JouName">Presented at ECTRIMS 2021 Virtual Congress. </span> 
</li>

<li> Freidman-Korn T, <span class="NameBold">Rechtman A</span>, Zveik O, Vaknin-Dembinsky A (2024)
    <br class="AritcleListBrake">
    <span class="ArtTitle"> Repeated MRI-Negative Demyelinating Attacks Linked to MOG-IgG Antibodies and silent lesions- case series.  </span> 
<span class="JouName"> Accepted to be presented at the ECTRIMS 2024 Congress. </span> 
</li>

<li> Zveik O, <span class="NameBold">Rechtman A</span>, Ganz T, Vaknin-Dembinsky A (2024)
    <br class="AritcleListBrake">
    <span class="ArtTitle"> The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells. </span>  
<span class="JouName"> Accepted to be presented at the ECTRIMS 2024 Congress. </span> 
</li>

<li> Zveik O, <span class="NameBold">Rechtman A</span>, Brill L, Vaknin-Dembinsky A (2024)
    <br class="AritcleListBrake">
    <span class="ArtTitle"> Anti- and pro-inflammatory milieu differentially regulate differentiation and immune functions of oligodendrocyte progenitor cells.  </span>  
<span class="JouName"> Accepted to be presented at the ECTRIMS 2024 Congress. </span> 
</li>


<li> Ganz T, Zveik O, Fainstein N, Lachis M, <span class="NameBold">Rechtman A</span>, Sofer L, Brill L, Ben-Hur T, Vaknin-Dembinsky A. (2024)
    <br class="AritcleListBrake">
    <span class="ArtTitle"> Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS. </span>  
<span class="JouName"> Presented at the annual meeting of the Israeli Neurological Association. </span> 
</li>
<li> Ganz T, Zveik O, Fainstein N, Lachis M, <span class="NameBold">Rechtman A</span>, Sofer L, Brill L, Ben-Hur T, Vaknin-Dembinsky A. (2024)
    <br class="AritcleListBrake">
    <span class="ArtTitle"> Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS. </span>  
<span class="JouName"> Presented at the American Academy of Neurology 2024 annual meeting. </span> 
</li>

<li> Ganz T, Zveik O, Fainstein N, Lachis M, <span class="NameBold">Rechtman A</span>, Sofer L, Brill L, Ben-Hur T, Vaknin-Dembinsky A.
    <br class="AritcleListBrake">
    <span class="ArtTitle">Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS. </span>  
<span class="JouName">Presented at the joint ECTRIMS-ACTRIMS MSMILAN2023 Congress.</span> 
</li>
<li> Ganz T, Zveik O, Fainstein N, Lachis M, <span class="NameBold">Rechtman A</span>, Sofer L, Brill L, Ben-Hur T, Vaknin-Dembinsky A.
    <br class="AritcleListBrake">
    <span class="ArtTitle">Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS.</span>  
<span class="JouName">Presented at the International Congress of Neuroimmunology 2023 ISNI Congress.</span> 
</li>
<li> Kahila S, Zveik O, Levin N, Brill L, <span class="NameBold">Rechtman A</span>, Haham N, Inbar T, and Vaknin-Dembinsky A. (2023)
    <br class="AritcleListBrake">
    <span class="ArtTitle">Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple sclerosis. </span>  
<span class="JouName">Presented at the American Academy of Neurology 2023 annual meeting.</span> 
</li>
<li> Kahila S, Zveik O, Levin N, Brill L, <span class="NameBold">Rechtman A</span>, Haham N, Inbar T, and Vaknin-Dembinsky A. (2022)
    <br class="AritcleListBrake">
    <span class="ArtTitle">Brain MRI activity during the year before pregnancy can predict clinical worsening in patients with Multiple sclerosis. </span>  
<span class="JouName">Presented at the annual meeting of the Israeli Neurological Association.</span> 
</li>
<li> Zveik O, <span class="NameBold">Rechtman A</span>, Haham N, Adini I, Canello T, Lavon I, Brill L, Vaknin-Dembinsky A. (2022)
    <br class="AritcleListBrake">
    <span class="ArtTitle">Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes. </span>  
<span class="JouName">Presented at the ECTRIMS 2022 Congress.</span> 
</li>
<li> Kahila S, Zveik O, Levin N, Brill L, <span class="NameBold">Rechtman A</span>, Haham N, Inbar T, and Vaknin-Dembinsky A. (2022) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">Brain MRI activity during the year before pregnancy can predict clinical worsening in patients with Multiple sclerosis. </span>  
<span class="JouName">Presented at the ECTRIMS 2022 Congress.</span> 
</li>
<li> Zveik O, Fainstein N, <span class="NameBold">Rechtman A</span>, Haham N, Ganz T, Brill L, Vaknin-Dembinsky A. (2022) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">Cerebrospinal fluid of Progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.</span>  
<span class="JouName">Presented at the ECTRIMS 2022 Congress.</span> 
</li>
<li> Uliel B, Brill L, <span class="NameBold">Rechtman A</span>, and Vaknin-Dembinsky A. (2021) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">ANTI LGI1 encephalitis, case series, and analysis of demographic, clinical and volumetric data. A possible new connection to neurodegenerative diseases?</span>  
<span class="JouName">Presented at the annual meeting of the Israeli Neurological Association. </span> 
</li>
<li> Haham N, Brill L, Rappoport N, Zveik O, <span class="NameBold">Rechtman A</span>, Vaknin-Dembinsky A. (2021) 
    <br class="AritcleListBrake">
    <span class="ArtTitle">Using circulatory biomarkers to predict disease progression in Multiple Sclerosis. </span>  
<span class="JouName">Presented at ECTRIMS 2021 Virtual Congress. </span> 
</li>
        </ul>
            <!-- Script -->
    <script src="script.js"></script>
    </section>
</body>